Research on the impact of traditional Chinese medicine registration innovation-oriented policies and enterprises performance: an empirical analysis based on listed enterprises in China

This study also indicates that R&D investment plays a mediating role in the effect of TCMRIPs on the performance of TCM listed enterprises in China, and the impact of policies on enterprise performance has a lag. The new version of the <i>Drug Registration Administration Measures</i>, the <i>TCM registration classification</i>, and the mechanisms they bring can promote the improvement of enterprise performance more effectively than the previous policies and mechanisms.